Ginkgo Bioworks Inc.
DNA | NYSE
$7.98
+$0.10 (+1.27%)
At close: Sep 21, 2026, 4:00 PM ET
$7.86
-$0.12 (-1.50%)
Pre-market:
Sep 22, 2026, 7:54 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -1.47 | -0.93 | -3.68 | -1.35 | -6.17 | -101.96 |
PEG Ratio | 0.03 | 0.02 | 0.06 | 0.20 | 0 | 23.51 |
PS Ratio | 2.71 | 2.24 | 13.05 | 5.93 | 34.90 | 167.14 |
PB Ratio | 0.91 | 0.71 | 2.99 | 1.63 | 7.28 | 27.77 |
P/FCF Ratio | -2.58 | -1.33 | -9.75 | -9.31 | -35.30 | -66.16 |
P/OCF Ratio | -2.69 | -1.59 | -11.10 | -11.24 | -43.16 | -94.33 |
OCF/S Ratio | -100.53 | -140.76 | -117.52 | -52.79 | -80.88 | -177.19 |
Debt / Equity Ratio | 0.86 | 0.65 | 0.22 | 0.25 | 0.02 | 0.04 |
Quick Ratio | 4.92 | 5.62 | 6.11 | 8.36 | 12.76 | 5.70 |
Current Ratio | 4.92 | 5.62 | 6.11 | 8.38 | 12.79 | 5.83 |
Asset Turnover | 0.15 | 0.16 | 0.15 | 0.19 | 0.15 | 0.11 |
Interest Coverage | n/a | -5.95K | -9.29K | -20.84K | -770.53 | -57.45 |
Return on Equity | -61.50% | -76.39% | -81.38% | -121.23% | -121.57% | -27.44% |
Return on Assets | -27.93% | -39.71% | -53.61% | -82.89% | -88.37% | -18.75% |
Return on Invested Capital | -30.05% | -43.05% | -56.90% | -91.55% | -94.32% | -22.75% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 81.48% | 83.02% | 78.52% | 57.25% | 58.68% | 79.64% |
Net Profit Margin | -183.81% | -240.94% | -355.08% | -440.63% | -583.12% | -165.16% |
Pretax Profit Margin | -184.30% | -241.15% | -355.11% | -444.08% | -585.69% | -162.85% |
Operating Profit Margin | -185.29% | -246.54% | -343.76% | -462.41% | -582.62% | -178.75% |
FCF Margin | -105.04% | -168.31% | -133.74% | -63.74% | -98.89% | -252.62% |
EBITDA Margin | -149.63% | -213.35% | -326.62% | -431.16% | -575.67% | -141.65% |
Add to Watchlist
Select watchlists to add or remove DNA